A

Aquestive Therapeutics
D

AQST

3.54000
USD
0.12
(3.51%)
مغلق
حجم التداول
117,294
الربح لكل سهم
-1
العائد الربحي
-
P/E
-6
حجم السوق
351,620,865
أصول ذات صلة
A
ACRE
-0.07500
(-1.52%)
4.85500 USD
A
ADMA
-0.410
(-1.97%)
20.400 USD
ALNY
ALNY
1.05
(0.34%)
309.05 USD
A
ANIP
1.800
(2.88%)
64.370 USD
A
ARWR
-0.050
(-0.32%)
15.700 USD
A
AXSM
-2.420
(-2.33%)
101.640 USD
B
BCRX
-0.070
(-0.68%)
10.290 USD
B
BHC
-0.08000
(-1.34%)
5.90500 USD
C
CRBP
-0.11000
(-1.25%)
8.72000 USD
المزيد
الأخبار المقالات

العنوان: Aquestive Therapeutics

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.